Case number: 3:17-bk-10315 - Enzyme Formulations, Inc. - Wisconsin Western Bankruptcy Court

Case Information
  • Case title

    Enzyme Formulations, Inc.

  • Court

    Wisconsin Western (wiwbke)

  • Chapter

    11

  • Judge

    Catherine J. Furay

  • Filed

    02/03/2017

  • Last Filing

    09/28/2017

  • Asset

    Yes

  • Vol

    v

Docket Header
PLNDUE, DSCLSDUE, LEAD



U.S. Bankruptcy Court
Western District of Wisconsin, http://www.wiwb.uscourts.gov (Madison)
Bankruptcy Petition #: 3-17-10315-cjf

341 Hearing Location: Madison
Assigned to: Chief Judge Catherine J. Furay
Chapter 11
Voluntary
Asset

Associated Case(s):


Date filed:  02/03/2017
341 meeting (341mtg):  03/09/2017

Debtor

Enzyme Formulations, Inc.

6421 Enterprise Lane
Madison, WI 53719
DANE-WI
608-273-8100
Tax ID / EIN: 39-1809388
represented by
Matthew D. Lee

150 E. Gilman Street
P.O. Box 1497
Madison, WI 53703
608/258-4203
Email: mdlee@foley.com

U.S. Trustee

U.S. Trustee's Office

U.S. Trustee's Office
Suite 304
780 Regent Street
Madison, WI 53715
 
 

Latest Dockets

Date Filed#Docket Text
03/03/201783List of 20 Largest Unsecured Creditors filed by Matthew D. Lee on behalf of Enzyme Formulations, Inc.. (Lee, Matthew) (Entered: 03/03/2017)
03/03/201782Declaration filed by Matthew D. Lee on behalf of Enzyme Formulations, Inc.. Related document(s) 81 Schedules and Statements filed by Debtor Enzyme Formulations, Inc.. (Lee, Matthew) (Entered: 03/03/2017)
03/03/201781Summary of Assets and Liabilities, Schedule A/B, Schedule D, Schedule E/F, Schedule G, Schedule H, Statement of Financial Affairs, filed by Matthew D. Lee on behalf of Enzyme Formulations, Inc.. (Lee, Matthew) (Entered: 03/03/2017)
03/03/201780Notice of Appearance and Request for Notice and Consent to E-Service for Attorney Megan R. Stelljes filed by Matthew D. Lee on behalf of Enzyme Formulations, Inc.. (Lee, Matthew) (Entered: 03/03/2017)
03/02/201779Final Order (a) PROHIBITING UTILITY COMPANIES FROM ALTERING, REFUSING, OR DISCONTINUING SERVICES TO THE DEBTORS; (b) DEEMING UTILITY COMPANIES ADEQUATELY ASSURED OF FUTURE PERFORMANCE; AND (c) ESTABLISHING PROCEDURES TO DETERMINE REQUESTS FOR ADDITIONAL ADEQUATE ASSURANCE OF PAYMENTS cc: parties in int. (Related Doc # 5) Signed on 3/2/2017. (Madison, Tina) (Entered: 03/03/2017)
03/02/201778Periodic Report Regarding Value, Operations and Profitability of Entities in Which the Estate of Howard F. Loomis, Jr. Holds a Substantial or Controlling Interest filed by Matthew D. Lee on behalf of Enzyme Formulations, Inc.. (Lee, Matthew) (Entered: 03/02/2017)
02/28/201777PM/Final Hearing Held on Chapter 11 First Day Motion FOR INTERIM AND FINAL ORDERS (a) PROHIBITING UTILITY PROVIDERS FROM ALTERING, REFUSING, OR DISCONTINUING SERVICES TO THE DEBTORS; (b) DEEMING UTILITY PROVIDERS ADEQUATELY ASSURED OF FUTURE PERFORMANCE; AND (c) ESTABLISHING PROCEDURES TO DETERMINE REQUESTS FOR ADDITIONAL ADEQUATE ASSURANCE. OUTCOME: Granted; proposed order previously submitted to be signed (related document(s): 5 (tm ) (Entered: 02/28/2017)
02/21/201776Attorney Fee Disclosure, filed by Matthew D. Lee on behalf of Enzyme Formulations, Inc.. (Lee, Matthew) (Entered: 02/21/2017)
02/17/201775Proof of Service filed by Matthew D. Lee on behalf of Enzyme Formulations, Inc.. Related document(s) 72, 73, 74 Motion to Set Last Day to File Proofs of Claim filed by Debtor Enzyme Formulations, Inc., Notice of Motion filed by Debtor Enzyme Formulations, Inc., Proposed Order filed by Debtor Enzyme Formulations, Inc.. (Lee, Matthew) (Entered: 02/17/2017)
02/16/201774Proposed Order (related document(s) 72 Motion to Set Last Day to File Proofs of Claim filed by Debtor Enzyme Formulations, Inc.) filed by Attorney Matthew D. Lee on behalf of Enzyme Formulations, Inc. . Order to be signed on or after 3/2/2017. (Lee, Matthew) (Entered: 02/16/2017)